MAS review group
CDL may catch up with its soaring peers
The developer has been actively unlocking value, but is trading at a much steeper discount to RNAV than UOL
Secondary listings on SGX set to grow in 2026, but regulatory frictions loom
Well-known companies with such listings here include DFI Retail Group, IHH Healthcare, Nio and Prudential
SGX-Nasdaq bridge may be a model for more dual-listing arrangements with other jurisdictions
With the STI delivering strong returns, companies that choose to list in Singapore have to be prepared to compete for the attention of local investors
Is S$5 billion enough? Panel weighs impact of EQDP on Singapore equity valuations
There is agreement that the sum has kickstarted things, and that the challenge would be to keep up the momentum built in 2025
Singapore could see more IPOs in 2026 after public listing rebound last year
More than 30 companies have begun preparatory work for listings, evenly split between the SGX mainboard and Catalist
A Trump-inspired ‘Big Beautiful’ baby bonus could help birth the next boom for Singapore equities
It wouldn’t cost much relatively, and it could pave the way for stock investments to be part of our lives – while helping to make SGX great again
Singapore market reforms may lift sentiment in 2026 despite geopolitical, trade uncertainty
Investors should focus on companies with credible and clearly stated plans to drive shareholder value
Small and mid-cap firms hope Value Unlock measure will boost understanding of their businesses
This could lead to better market valuations and stronger investor confidence
Asset manager Lion Global Investors bets on mid-caps and gold investments
CEO Teo Joo Wah notes that the mid-cap segment is more labour-intensive in terms of research effort but is optimistic that it will pay off
SGX-Nasdaq dual-listing bridge may afford GIC, Temasek bigger role in revitalising local market
MAS says EQDP and the Anchor Fund @ 65 will support fundraising activity and trading liquidity on the new Global Listing Board
